Publications of Katharina Zettl

Journal Article (12)

1.
Journal Article
Harwood, M. D.; Zettl, K.; Weinheimer, M.; Pilla-Reddy, V.; Shen, H.; Jacobs, F.; Chu, X.; Huth, F.; Nakakariya, M.; Chothe, P. P. et al.; Neuhoff, S.; Wiśniewski, J. R.: Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome. Molecular Pharmaceutics 20 (7), pp. 3505 - 3518 (2023)
2.
Journal Article
Oron, M.; Grochowski, M.; Jaiswar, A.; Legierska, J.; Jastrzebski, K.; Nowak-Niezgoda, M.; Kolos, M.; Kazmierczak, W.; Olesinski, T.; Lenarcik, M. et al.; Cybulska, M.; Mikula, M.; Zylicz, A.; Miaczynska, M.; Zettl, K.; Wisniewski, J. R.; Walerych, D.: The molecular network of the proteasome machinery inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cells. Cell Reports 40 (13), 111428 (2022)
3.
Journal Article
Vessby, J.; Wisniewski, J. R.; Lindskog, C.; Eriksson, N.; Gabrysch, K.; Zettl, K.; Wanders, A.; Carlson, M.; Rorsman, F.; Aberg, M.: AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis. Clinical and Translational Gastroenterology 13 (5), e00486 (2022)
4.
Journal Article
Rosales, M.; Rodriguez-Ulloa, A.; Perez, G. V.; Besada, V.; Soto, T.; Ramos, Y.; Gonzalez, L. J.; Zettl, K.; Wisniewski, J. R.; Yang, K. et al.; Perera, Y.; Perea, S. E.: CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition. Frontiers in Molecular Biosciences 9, 834814 (2022)
5.
Journal Article
Bryk, A. H.; Zettl, K.; Wisniewski, J. R.; Undas, A.: Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid. Thrombosis Research 198, pp. 93 - 98 (2021)
6.
Journal Article
Rosales, M.; Perez V, G.; Ramon, A. C.; Cruz, Y.; Rodriguez-Ulloa, A.; Besada, V.; Ramos, Y.; Vazquez-Blomquist, D.; Caballero, E.; Aguilar, D. et al.; Gonzalez, L. J.; Zettl, K.; Wiśniewski, J. R.; Yang, K.; Perera, Y.; Perea, S. E.: Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300. Biomedicines 9 (7), 766 (2021)
7.
Journal Article
Rosales, M.; Rodriguez-Ulloa, A.; Besada, V.; Ramon, A. C.; Perez, G. V.; Ramos, Y.; Guirola, O.; Gonzalez, L. J.; Zettl, K.; Wisniewski, J. R. et al.; Perera, Y.; Perea, S. E.: Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945. Cells 10 (2), 338 (2021)
8.
Journal Article
Wegler, C.; Olander, M.; Wisniewski, J. R.; Lundquist, P.; Zettl, K.; Asberg, A.; Hjelmesaeth, J.; Andersson, T. B.; Artursson, P.: Global variability analysis of mRNA and protein concentrations across and within human tissues. NAR: genomics and bioinformatics 2 (1), lqz010 (2020)
9.
Journal Article
Bryk, A. H.; Natorska, J.; Zabczyk, M.; Zettl, K.; Wiśniewski, J. R.; Undas, A.: Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties. Journal of proteomics 229, 103946 (2020)
10.
Journal Article
Wisniewski, J. R.; Zettl, K.; Pilch, M.; Rysiewicz, B.; Sadok, I.: 'Shotgun' proteomic analyses without alkylation of cysteine. ANALYTICA CHIMICA ACTA 1100, pp. 131 - 137 (2020)
11.
Journal Article
Zabczyk, M.; Natorska, J.; Bagoly, Z.; Sarkady, F.; Barath, B.; Katona, E.; Bryk, A.; Zettl, K.; Wisniewski, J. R.; Undas, A.: Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase. Journal of Physiology and Pharmacology 71 (4), pp. 519 - 524 (2020)
12.
Journal Article
Wisniewski, J. R.; Zettl, K.: Datasets: Sensitivity and protein digestion course of proteomic Filter Aided Sample Preparation. DATA IN BRIEF 26, 104530 (2019)
Go to Editor View